Global Cell and Advanced Therapies Supply Chain Management Market Growth (Status and Outlook) 2026-2032

July 2026 | 192 pages | ID: G309E9389F00EN
LP Information

Abstracts

The global Cell and Advanced Therapies Supply Chain Management market size is predicted to grow from US$ 1037 million in 2025 to US$ 1717 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to 2032.

Cell and Advanced Therapies Supply Chain Management is a systematic approach to resource planning, traceability, and compliance management for cell therapy, gene therapy, and tissue engineering products, encompassing the entire process from collection, production, cold chain transportation to final clinical application. It covers therapies including CAR-T, TCR-T, stem cells, oncolytic viruses, and gene editing products. Core management stages include: donor material collection and transportation, plasmid/viral vector production, cell engineering and amplification, quality control and release, liquid nitrogen cryogenic storage, and patient reinfusion. This supply chain must strictly adhere to GMP/GTP standards and achieve end-to-end cold chain temperature monitoring (-196?C to -80?C) and on-chain traceability (batch, chain identity). Dedicated supply chain software is typically used to interface with ERP and clinical trial systems and is applied by pharmaceutical companies, CROs/CDMOs, and advanced therapeutic hospitals. Its goal is to ensure product quality stability, reduce transportation losses, and achieve full compliance throughout the process.

market is dominated by North America, led by European standards, and experiencing accelerated manufacturing and clinical applications in the Asia-Pacific region. North America (primarily the US) boasts mature commercial products such as CAR-T, driven by capital investment in vertical SaaS and hardware integration. Europe emphasizes end-to-end compliance and data privacy, with SAP Life Sciences Solutions and MAK-SYSTEM focusing on GMP-level manufacturing and transportation traceability. EMA regulations are driving the demand for closed-loop management of advanced therapies in hospitals. The Asia-Pacific region (China, Japan, and South Korea) is experiencing a surge in cell therapy clinical pipelines and policy support, leading companies like Genscript, WuXi AppTec, and NIPRO to rapidly localize their supply chains and accelerate their integration into international chains. Future trends include end-to-end blockchain traceability, automated liquid nitrogen storage and delivery via IoT, and integration with electronic medical data for cell therapy. Obstacles include the stability risks of multi-temperature cold chains (-80?C to -196?C), extremely narrow time windows from single-collection to reinfusion, and a lack of globally recognized digital interoperability standards.

LPI (LP Information)' newest research report, the ?Cell and Advanced Therapies Supply Chain Management Industry Forecast? looks at past sales and reviews total world Cell and Advanced Therapies Supply Chain Management sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell and Advanced Therapies Supply Chain Management sales for 2026 through 2032. With Cell and Advanced Therapies Supply Chain Management sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell and Advanced Therapies Supply Chain Management industry.

This Insight Report provides a comprehensive analysis of the global Cell and Advanced Therapies Supply Chain Management landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell and Advanced Therapies Supply Chain Management portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Cell and Advanced Therapies Supply Chain Management market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell and Advanced Therapies Supply Chain Management and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell and Advanced Therapies Supply Chain Management.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Advanced Therapies Supply Chain Management market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Cloud
• On-premises

Segmentation by Supply Chain:

• Collection
• Production and Manufacturing
• Cold Chain Transportation
• Storage
• Clinical Use
• Others

Segmentation by Temperature:

• Ambient Temperature (15-25?C)
• Refrigerated (2-8?C)
• Frozen (-20?C)
• Deep-frozen (-80?C)
• Cryogenic Temperature (-196?C)

Segmentation by Application:

• Biobank
• Cell Therapy Lab
• Hospital
• Research Institute
• Commercial Organization

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Thermo Fisher Scientific
• BioLife Solutions
• Azenta
• Modality Solutions
• PCA
• QuickSTAT
• Be The Match BioTherapies
• Brooks Life Sciences
• Cryoport
• Haemonetics
• Hypertrust Patient Data Care
• Lykan Bioscience
• MAK-SYSTEM
• MasterControl
• SAP
• SAVSU Technologies
• sedApta Group
• Stafa Cellular Therapy
• Title21 Health Solutions
• TraceLink
• TrakCel
• Vineti
• Lonza
• Sartorius
• BioOutsource
• GenScript
• WuXi AppTec
• Pharmaron
• JOINN
• NIPRO
• Kawasaki Heavy Industries
• JCR Pharmaceuticals
• Fujifilm Cellular Dynamics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cell and Advanced Therapies Supply Chain Management Market Size (2021-2032)
  2.1.2 Cell and Advanced Therapies Supply Chain Management Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Cell and Advanced Therapies Supply Chain Management by Country/Region (2021, 2025 & 2032)
2.2 Cell and Advanced Therapies Supply Chain Management Segment by Type
  2.2.1 Cloud
  2.2.2 On-premises
  2.2.3 Cell and Advanced Therapies Supply Chain Management Market Size by Type
    2.2.3.1 Cell and Advanced Therapies Supply Chain Management Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2021-2026)
2.3 Cell and Advanced Therapies Supply Chain Management Segment by Supply Chain
  2.3.1 Collection
  2.3.2 Production and Manufacturing
  2.3.3 Cold Chain Transportation
  2.3.4 Storage
  2.3.5 Clinical Use
  2.3.6 Others
  2.3.7 Cell and Advanced Therapies Supply Chain Management Market Size by Supply Chain
    2.3.7.1 Cell and Advanced Therapies Supply Chain Management Market Size CAGR by Supply Chain (2021 VS 2025 VS 2032)
    2.3.7.2 Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Supply Chain (2021-2026)
2.4 Cell and Advanced Therapies Supply Chain Management Segment by Temperature
  2.4.1 Ambient Temperature (15-25?C)
  2.4.2 Refrigerated (2-8?C)
  2.4.3 Frozen (-20?C)
  2.4.4 Deep-frozen (-80?C)
  2.4.5 Cryogenic Temperature (-196?C)
  2.4.6 Cell and Advanced Therapies Supply Chain Management Market Size by Temperature
    2.4.6.1 Cell and Advanced Therapies Supply Chain Management Market Size CAGR by Temperature (2021 VS 2025 VS 2032)
    2.4.6.2 Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Temperature (2021-2026)
2.5 Cell and Advanced Therapies Supply Chain Management Segment by Application
  2.5.1 Biobank
  2.5.2 Cell Therapy Lab
  2.5.3 Hospital
  2.5.4 Research Institute
  2.5.5 Commercial Organization
  2.5.6 Cell and Advanced Therapies Supply Chain Management Market Size by Application
    2.5.6.1 Cell and Advanced Therapies Supply Chain Management Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.5.6.2 Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2021-2026)

3 CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE BY PLAYER

3.1 Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Player
  3.1.1 Global Cell and Advanced Therapies Supply Chain Management Revenue by Player (2021-2026)
  3.1.2 Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Player (2021-2026)
3.2 Global Cell and Advanced Therapies Supply Chain Management Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT BY REGION

4.1 Cell and Advanced Therapies Supply Chain Management Market Size by Region (2021-2026)
4.2 Global Cell and Advanced Therapies Supply Chain Management Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell and Advanced Therapies Supply Chain Management Market Size Growth (2021-2026)
4.4 APAC Cell and Advanced Therapies Supply Chain Management Market Size Growth (2021-2026)
4.5 Europe Cell and Advanced Therapies Supply Chain Management Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Cell and Advanced Therapies Supply Chain Management Market Size by Country (2021-2026)
5.2 Americas Cell and Advanced Therapies Supply Chain Management Market Size by Type (2021-2026)
5.3 Americas Cell and Advanced Therapies Supply Chain Management Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cell and Advanced Therapies Supply Chain Management Market Size by Region (2021-2026)
6.2 APAC Cell and Advanced Therapies Supply Chain Management Market Size by Type (2021-2026)
6.3 APAC Cell and Advanced Therapies Supply Chain Management Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Country (2021-2026)
7.2 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Type (2021-2026)
7.3 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cell and Advanced Therapies Supply Chain Management by Region (2021-2026)
8.2 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET FORECAST

10.1 Global Cell and Advanced Therapies Supply Chain Management Forecast by Region (2027-2032)
  10.1.1 Global Cell and Advanced Therapies Supply Chain Management Forecast by Region (2027-2032)
  10.1.2 Americas Cell and Advanced Therapies Supply Chain Management Forecast
  10.1.3 APAC Cell and Advanced Therapies Supply Chain Management Forecast
  10.1.4 Europe Cell and Advanced Therapies Supply Chain Management Forecast
  10.1.5 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Forecast
10.2 Americas Cell and Advanced Therapies Supply Chain Management Forecast by Country (2027-2032)
  10.2.1 United States Market Cell and Advanced Therapies Supply Chain Management Forecast
  10.2.2 Canada Market Cell and Advanced Therapies Supply Chain Management Forecast
  10.2.3 Mexico Market Cell and Advanced Therapies Supply Chain Management Forecast
  10.2.4 Brazil Market Cell and Advanced Therapies Supply Chain Management Forecast
10.3 APAC Cell and Advanced Therapies Supply Chain Management Forecast by Region (2027-2032)
  10.3.1 China Cell and Advanced Therapies Supply Chain Management Market Forecast
  10.3.2 Japan Market Cell and Advanced Therapies Supply Chain Management Forecast
  10.3.3 Korea Market Cell and Advanced Therapies Supply Chain Management Forecast
  10.3.4 Southeast Asia Market Cell and Advanced Therapies Supply Chain Management Forecast
  10.3.5 India Market Cell and Advanced Therapies Supply Chain Management Forecast
  10.3.6 Australia Market Cell and Advanced Therapies Supply Chain Management Forecast
10.4 Europe Cell and Advanced Therapies Supply Chain Management Forecast by Country (2027-2032)
  10.4.1 Germany Market Cell and Advanced Therapies Supply Chain Management Forecast
  10.4.2 France Market Cell and Advanced Therapies Supply Chain Management Forecast
  10.4.3 UK Market Cell and Advanced Therapies Supply Chain Management Forecast
  10.4.4 Italy Market Cell and Advanced Therapies Supply Chain Management Forecast
  10.4.5 Russia Market Cell and Advanced Therapies Supply Chain Management Forecast
10.5 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Forecast by Region (2027-2032)
  10.5.1 Egypt Market Cell and Advanced Therapies Supply Chain Management Forecast
  10.5.2 South Africa Market Cell and Advanced Therapies Supply Chain Management Forecast
  10.5.3 Israel Market Cell and Advanced Therapies Supply Chain Management Forecast
  10.5.4 Turkey Market Cell and Advanced Therapies Supply Chain Management Forecast
10.6 Global Cell and Advanced Therapies Supply Chain Management Forecast by Type (2027-2032)
10.7 Global Cell and Advanced Therapies Supply Chain Management Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Cell and Advanced Therapies Supply Chain Management Forecast

11 KEY PLAYERS ANALYSIS

11.1 Thermo Fisher Scientific
  11.1.1 Thermo Fisher Scientific Company Information
  11.1.2 Thermo Fisher Scientific Cell and Advanced Therapies Supply Chain Management Product Offered
  11.1.3 Thermo Fisher Scientific Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Thermo Fisher Scientific Main Business Overview
  11.1.5 Thermo Fisher Scientific Latest Developments
11.2 BioLife Solutions
  11.2.1 BioLife Solutions Company Information
  11.2.2 BioLife Solutions Cell and Advanced Therapies Supply Chain Management Product Offered
  11.2.3 BioLife Solutions Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 BioLife Solutions Main Business Overview
  11.2.5 BioLife Solutions Latest Developments
11.3 Azenta
  11.3.1 Azenta Company Information
  11.3.2 Azenta Cell and Advanced Therapies Supply Chain Management Product Offered
  11.3.3 Azenta Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Azenta Main Business Overview
  11.3.5 Azenta Latest Developments
11.4 Modality Solutions
  11.4.1 Modality Solutions Company Information
  11.4.2 Modality Solutions Cell and Advanced Therapies Supply Chain Management Product Offered
  11.4.3 Modality Solutions Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Modality Solutions Main Business Overview
  11.4.5 Modality Solutions Latest Developments
11.5 PCA
  11.5.1 PCA Company Information
  11.5.2 PCA Cell and Advanced Therapies Supply Chain Management Product Offered
  11.5.3 PCA Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 PCA Main Business Overview
  11.5.5 PCA Latest Developments
11.6 QuickSTAT
  11.6.1 QuickSTAT Company Information
  11.6.2 QuickSTAT Cell and Advanced Therapies Supply Chain Management Product Offered
  11.6.3 QuickSTAT Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 QuickSTAT Main Business Overview
  11.6.5 QuickSTAT Latest Developments
11.7 Be The Match BioTherapies
  11.7.1 Be The Match BioTherapies Company Information
  11.7.2 Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Product Offered
  11.7.3 Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Be The Match BioTherapies Main Business Overview
  11.7.5 Be The Match BioTherapies Latest Developments
11.8 Brooks Life Sciences
  11.8.1 Brooks Life Sciences Company Information
  11.8.2 Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Product Offered
  11.8.3 Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Brooks Life Sciences Main Business Overview
  11.8.5 Brooks Life Sciences Latest Developments
11.9 Cryoport
  11.9.1 Cryoport Company Information
  11.9.2 Cryoport Cell and Advanced Therapies Supply Chain Management Product Offered
  11.9.3 Cryoport Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Cryoport Main Business Overview
  11.9.5 Cryoport Latest Developments
11.10 Haemonetics
  11.10.1 Haemonetics Company Information
  11.10.2 Haemonetics Cell and Advanced Therapies Supply Chain Management Product Offered
  11.10.3 Haemonetics Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Haemonetics Main Business Overview
  11.10.5 Haemonetics Latest Developments
11.11 Hypertrust Patient Data Care
  11.11.1 Hypertrust Patient Data Care Company Information
  11.11.2 Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Product Offered
  11.11.3 Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Hypertrust Patient Data Care Main Business Overview
  11.11.5 Hypertrust Patient Data Care Latest Developments
11.12 Lykan Bioscience
  11.12.1 Lykan Bioscience Company Information
  11.12.2 Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Product Offered
  11.12.3 Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 Lykan Bioscience Main Business Overview
  11.12.5 Lykan Bioscience Latest Developments
11.13 MAK-SYSTEM
  11.13.1 MAK-SYSTEM Company Information
  11.13.2 MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Product Offered
  11.13.3 MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 MAK-SYSTEM Main Business Overview
  11.13.5 MAK-SYSTEM Latest Developments
11.14 MasterControl
  11.14.1 MasterControl Company Information
  11.14.2 MasterControl Cell and Advanced Therapies Supply Chain Management Product Offered
  11.14.3 MasterControl Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.14.4 MasterControl Main Business Overview
  11.14.5 MasterControl Latest Developments
11.15 SAP
  11.15.1 SAP Company Information
  11.15.2 SAP Cell and Advanced Therapies Supply Chain Management Product Offered
  11.15.3 SAP Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.15.4 SAP Main Business Overview
  11.15.5 SAP Latest Developments
11.16 SAVSU Technologies
  11.16.1 SAVSU Technologies Company Information
  11.16.2 SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Product Offered
  11.16.3 SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.16.4 SAVSU Technologies Main Business Overview
  11.16.5 SAVSU Technologies Latest Developments
11.17 sedApta Group
  11.17.1 sedApta Group Company Information
  11.17.2 sedApta Group Cell and Advanced Therapies Supply Chain Management Product Offered
  11.17.3 sedApta Group Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.17.4 sedApta Group Main Business Overview
  11.17.5 sedApta Group Latest Developments
11.18 Stafa Cellular Therapy
  11.18.1 Stafa Cellular Therapy Company Information
  11.18.2 Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Product Offered
  11.18.3 Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.18.4 Stafa Cellular Therapy Main Business Overview
  11.18.5 Stafa Cellular Therapy Latest Developments
11.19 Title21 Health Solutions
  11.19.1 Title21 Health Solutions Company Information
  11.19.2 Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Product Offered
  11.19.3 Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.19.4 Title21 Health Solutions Main Business Overview
  11.19.5 Title21 Health Solutions Latest Developments
11.20 TraceLink
  11.20.1 TraceLink Company Information
  11.20.2 TraceLink Cell and Advanced Therapies Supply Chain Management Product Offered
  11.20.3 TraceLink Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.20.4 TraceLink Main Business Overview
  11.20.5 TraceLink Latest Developments
11.21 TrakCel
  11.21.1 TrakCel Company Information
  11.21.2 TrakCel Cell and Advanced Therapies Supply Chain Management Product Offered
  11.21.3 TrakCel Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.21.4 TrakCel Main Business Overview
  11.21.5 TrakCel Latest Developments
11.22 Vineti
  11.22.1 Vineti Company Information
  11.22.2 Vineti Cell and Advanced Therapies Supply Chain Management Product Offered
  11.22.3 Vineti Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.22.4 Vineti Main Business Overview
  11.22.5 Vineti Latest Developments
11.23 Lonza
  11.23.1 Lonza Company Information
  11.23.2 Lonza Cell and Advanced Therapies Supply Chain Management Product Offered
  11.23.3 Lonza Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.23.4 Lonza Main Business Overview
  11.23.5 Lonza Latest Developments
11.24 Sartorius
  11.24.1 Sartorius Company Information
  11.24.2 Sartorius Cell and Advanced Therapies Supply Chain Management Product Offered
  11.24.3 Sartorius Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.24.4 Sartorius Main Business Overview
  11.24.5 Sartorius Latest Developments
11.25 BioOutsource
  11.25.1 BioOutsource Company Information
  11.25.2 BioOutsource Cell and Advanced Therapies Supply Chain Management Product Offered
  11.25.3 BioOutsource Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.25.4 BioOutsource Main Business Overview
  11.25.5 BioOutsource Latest Developments
11.26 GenScript
  11.26.1 GenScript Company Information
  11.26.2 GenScript Cell and Advanced Therapies Supply Chain Management Product Offered
  11.26.3 GenScript Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.26.4 GenScript Main Business Overview
  11.26.5 GenScript Latest Developments
11.27 WuXi AppTec
  11.27.1 WuXi AppTec Company Information
  11.27.2 WuXi AppTec Cell and Advanced Therapies Supply Chain Management Product Offered
  11.27.3 WuXi AppTec Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.27.4 WuXi AppTec Main Business Overview
  11.27.5 WuXi AppTec Latest Developments
11.28 Pharmaron
  11.28.1 Pharmaron Company Information
  11.28.2 Pharmaron Cell and Advanced Therapies Supply Chain Management Product Offered
  11.28.3 Pharmaron Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.28.4 Pharmaron Main Business Overview
  11.28.5 Pharmaron Latest Developments
11.29 JOINN
  11.29.1 JOINN Company Information
  11.29.2 JOINN Cell and Advanced Therapies Supply Chain Management Product Offered
  11.29.3 JOINN Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.29.4 JOINN Main Business Overview
  11.29.5 JOINN Latest Developments
11.30 NIPRO
  11.30.1 NIPRO Company Information
  11.30.2 NIPRO Cell and Advanced Therapies Supply Chain Management Product Offered
  11.30.3 NIPRO Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.30.4 NIPRO Main Business Overview
  11.30.5 NIPRO Latest Developments
11.31 Kawasaki Heavy Industries
  11.31.1 Kawasaki Heavy Industries Company Information
  11.31.2 Kawasaki Heavy Industries Cell and Advanced Therapies Supply Chain Management Product Offered
  11.31.3 Kawasaki Heavy Industries Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.31.4 Kawasaki Heavy Industries Main Business Overview
  11.31.5 Kawasaki Heavy Industries Latest Developments
11.32 JCR Pharmaceuticals
  11.32.1 JCR Pharmaceuticals Company Information
  11.32.2 JCR Pharmaceuticals Cell and Advanced Therapies Supply Chain Management Product Offered
  11.32.3 JCR Pharmaceuticals Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.32.4 JCR Pharmaceuticals Main Business Overview
  11.32.5 JCR Pharmaceuticals Latest Developments
11.33 Fujifilm Cellular Dynamics
  11.33.1 Fujifilm Cellular Dynamics Company Information
  11.33.2 Fujifilm Cellular Dynamics Cell and Advanced Therapies Supply Chain Management Product Offered
  11.33.3 Fujifilm Cellular Dynamics Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
  11.33.4 Fujifilm Cellular Dynamics Main Business Overview
  11.33.5 Fujifilm Cellular Dynamics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Cell and Advanced Therapies Supply Chain Management Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell and Advanced Therapies Supply Chain Management Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cloud
Table 4. Major Players of On-premises
Table 5. Cell and Advanced Therapies Supply Chain Management Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Cell and Advanced Therapies Supply Chain Management Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Collection
Table 9. Major Players of Production and Manufacturing
Table 10. Major Players of Cold Chain Transportation
Table 11. Major Players of Storage
Table 12. Major Players of Clinical Use
Table 13. Major Players of Others
Table 14. Cell and Advanced Therapies Supply Chain Management Market Size CAGR by Supply Chain (2021 VS 2025 VS 2032) & ($ millions)
Table 15. Global Cell and Advanced Therapies Supply Chain Management Market Size by Supply Chain (2021-2026) & ($ millions)
Table 16. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Supply Chain (2021-2026)
Table 17. Major Players of Ambient Temperature (15-25?C)
Table 18. Major Players of Refrigerated (2-8?C)
Table 19. Major Players of Frozen (-20?C)
Table 20. Major Players of Deep-frozen (-80?C)
Table 21. Major Players of Cryogenic Temperature (-196?C)
Table 22. Cell and Advanced Therapies Supply Chain Management Market Size CAGR by Temperature (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Cell and Advanced Therapies Supply Chain Management Market Size by Temperature (2021-2026) & ($ millions)
Table 24. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Temperature (2021-2026)
Table 25. Cell and Advanced Therapies Supply Chain Management Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 26. Global Cell and Advanced Therapies Supply Chain Management Market Size by Application (2021-2026) & ($ millions)
Table 27. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2021-2026)
Table 28. Global Cell and Advanced Therapies Supply Chain Management Revenue by Player (2021-2026) & ($ millions)
Table 29. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Player (2021-2026)
Table 30. Cell and Advanced Therapies Supply Chain Management Key Players Head office and Products Offered
Table 31. Cell and Advanced Therapies Supply Chain Management Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Mergers & Acquisitions, Expansion
Table 34. Global Cell and Advanced Therapies Supply Chain Management Market Size by Region (2021-2026) & ($ millions)
Table 35. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Region (2021-2026)
Table 36. Global Cell and Advanced Therapies Supply Chain Management Revenue by Country/Region (2021-2026) & ($ millions)
Table 37. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Country/Region (2021-2026)
Table 38. Americas Cell and Advanced Therapies Supply Chain Management Market Size by Country (2021-2026) & ($ millions)
Table 39. Americas Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Country (2021-2026)
Table 40. Americas Cell and Advanced Therapies Supply Chain Management Market Size by Type (2021-2026) & ($ millions)
Table 41. Americas Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2021-2026)
Table 42. Americas Cell and Advanced Therapies Supply Chain Management Market Size by Application (2021-2026) & ($ millions)
Table 43. Americas Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2021-2026)
Table 44. APAC Cell and Advanced Therapies Supply Chain Management Market Size by Region (2021-2026) & ($ millions)
Table 45. APAC Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Region (2021-2026)
Table 46. APAC Cell and Advanced Therapies Supply Chain Management Market Size by Type (2021-2026) & ($ millions)
Table 47. APAC Cell and Advanced Therapies Supply Chain Management Market Size by Application (2021-2026) & ($ millions)
Table 48. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Country (2021-2026) & ($ millions)
Table 49. Europe Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Country (2021-2026)
Table 50. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Type (2021-2026) & ($ millions)
Table 51. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Application (2021-2026) & ($ millions)
Table 52. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Region (2021-2026) & ($ millions)
Table 53. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Type (2021-2026) & ($ millions)
Table 54. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Application (2021-2026) & ($ millions)
Table 55. Key Market Drivers & Growth Opportunities of Cell and Advanced Therapies Supply Chain Management
Table 56. Key Market Challenges & Risks of Cell and Advanced Therapies Supply Chain Management
Table 57. Key Industry Trends of Cell and Advanced Therapies Supply Chain Management
Table 58. Global Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Region (2027-2032) & ($ millions)
Table 59. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share Forecast by Region (2027-2032)
Table 60. Global Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Type (2027-2032) & ($ millions)
Table 61. Global Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Application (2027-2032) & ($ millions)
Table 62. Thermo Fisher Scientific Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 63. Thermo Fisher Scientific Cell and Advanced Therapies Supply Chain Management Product Offered
Table 64. Thermo Fisher Scientific Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Thermo Fisher Scientific Main Business
Table 66. Thermo Fisher Scientific Latest Developments
Table 67. BioLife Solutions Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 68. BioLife Solutions Cell and Advanced Therapies Supply Chain Management Product Offered
Table 69. BioLife Solutions Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. BioLife Solutions Main Business
Table 71. BioLife Solutions Latest Developments
Table 72. Azenta Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 73. Azenta Cell and Advanced Therapies Supply Chain Management Product Offered
Table 74. Azenta Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Azenta Main Business
Table 76. Azenta Latest Developments
Table 77. Modality Solutions Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 78. Modality Solutions Cell and Advanced Therapies Supply Chain Management Product Offered
Table 79. Modality Solutions Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Modality Solutions Main Business
Table 81. Modality Solutions Latest Developments
Table 82. PCA Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 83. PCA Cell and Advanced Therapies Supply Chain Management Product Offered
Table 84. PCA Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. PCA Main Business
Table 86. PCA Latest Developments
Table 87. QuickSTAT Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 88. QuickSTAT Cell and Advanced Therapies Supply Chain Management Product Offered
Table 89. QuickSTAT Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. QuickSTAT Main Business
Table 91. QuickSTAT Latest Developments
Table 92. Be The Match BioTherapies Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 93. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Product Offered
Table 94. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Be The Match BioTherapies Main Business
Table 96. Be The Match BioTherapies Latest Developments
Table 97. Brooks Life Sciences Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 98. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Product Offered
Table 99. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Brooks Life Sciences Main Business
Table 101. Brooks Life Sciences Latest Developments
Table 102. Cryoport Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 103. Cryoport Cell and Advanced Therapies Supply Chain Management Product Offered
Table 104. Cryoport Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Cryoport Main Business
Table 106. Cryoport Latest Developments
Table 107. Haemonetics Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 108. Haemonetics Cell and Advanced Therapies Supply Chain Management Product Offered
Table 109. Haemonetics Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Haemonetics Main Business
Table 111. Haemonetics Latest Developments
Table 112. Hypertrust Patient Data Care Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 113. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Product Offered
Table 114. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Hypertrust Patient Data Care Main Business
Table 116. Hypertrust Patient Data Care Latest Developments
Table 117. Lykan Bioscience Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 118. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Product Offered
Table 119. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Lykan Bioscience Main Business
Table 121. Lykan Bioscience Latest Developments
Table 122. MAK-SYSTEM Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 123. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Product Offered
Table 124. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. MAK-SYSTEM Main Business
Table 126. MAK-SYSTEM Latest Developments
Table 127. MasterControl Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 128. MasterControl Cell and Advanced Therapies Supply Chain Management Product Offered
Table 129. MasterControl Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. MasterControl Main Business
Table 131. MasterControl Latest Developments
Table 132. SAP Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 133. SAP Cell and Advanced Therapies Supply Chain Management Product Offered
Table 134. SAP Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. SAP Main Business
Table 136. SAP Latest Developments
Table 137. SAVSU Technologies Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 138. SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Product Offered
Table 139. SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. SAVSU Technologies Main Business
Table 141. SAVSU Technologies Latest Developments
Table 142. sedApta Group Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 143. sedApta Group Cell and Advanced Therapies Supply Chain Management Product Offered
Table 144. sedApta Group Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 145. sedApta Group Main Business
Table 146. sedApta Group Latest Developments
Table 147. Stafa Cellular Therapy Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 148. Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Product Offered
Table 149. Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 150. Stafa Cellular Therapy Main Business
Table 151. Stafa Cellular Therapy Latest Developments
Table 152. Title21 Health Solutions Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 153. Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Product Offered
Table 154. Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 155. Title21 Health Solutions Main Business
Table 156. Title21 Health Solutions Latest Developments
Table 157. TraceLink Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 158. TraceLink Cell and Advanced Therapies Supply Chain Management Product Offered
Table 159. TraceLink Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 160. TraceLink Main Business
Table 161. TraceLink Latest Developments
Table 162. TrakCel Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 163. TrakCel Cell and Advanced Therapies Supply Chain Management Product Offered
Table 164. TrakCel Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 165. TrakCel Main Business
Table 166. TrakCel Latest Developments
Table 167. Vineti Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 168. Vineti Cell and Advanced Therapies Supply Chain Management Product Offered
Table 169. Vineti Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 170. Vineti Main Business
Table 171. Vineti Latest Developments
Table 172. Lonza Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 173. Lonza Cell and Advanced Therapies Supply Chain Management Product Offered
Table 174. Lonza Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 175. Lonza Main Business
Table 176. Lonza Latest Developments
Table 177. Sartorius Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 178. Sartorius Cell and Advanced Therapies Supply Chain Management Product Offered
Table 179. Sartorius Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 180. Sartorius Main Business
Table 181. Sartorius Latest Developments
Table 182. BioOutsource Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 183. BioOutsource Cell and Advanced Therapies Supply Chain Management Product Offered
Table 184. BioOutsource Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 185. BioOutsource Main Business
Table 186. BioOutsource Latest Developments
Table 187. GenScript Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 188. GenScript Cell and Advanced Therapies Supply Chain Management Product Offered
Table 189. GenScript Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 190. GenScript Main Business
Table 191. GenScript Latest Developments
Table 192. WuXi AppTec Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 193. WuXi AppTec Cell and Advanced Therapies Supply Chain Management Product Offered
Table 194. WuXi AppTec Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 195. WuXi AppTec Main Business
Table 196. WuXi AppTec Latest Developments
Table 197. Pharmaron Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 198. Pharmaron Cell and Advanced Therapies Supply Chain Management Product Offered
Table 199. Pharmaron Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 200. Pharmaron Main Business
Table 201. Pharmaron Latest Developments
Table 202. JOINN Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 203. JOINN Cell and Advanced Therapies Supply Chain Management Product Offered
Table 204. JOINN Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 205. JOINN Main Business
Table 206. JOINN Latest Developments
Table 207. NIPRO Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 208. NIPRO Cell and Advanced Therapies Supply Chain Management Product Offered
Table 209. NIPRO Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 210. NIPRO Main Business
Table 211. NIPRO Latest Developments
Table 212. Kawasaki Heavy Industries Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 213. Kawasaki Heavy Industries Cell and Advanced Therapies Supply Chain Management Product Offered
Table 214. Kawasaki Heavy Industries Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 215. Kawasaki Heavy Industries Main Business
Table 216. Kawasaki Heavy Industries Latest Developments
Table 217. JCR Pharmaceuticals Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 218. JCR Pharmaceuticals Cell and Advanced Therapies Supply Chain Management Product Offered
Table 219. JCR Pharmaceuticals Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 220. JCR Pharmaceuticals Main Business
Table 221. JCR Pharmaceuticals Latest Developments
Table 222. Fujifilm Cellular Dynamics Details, Company Type, Cell and Advanced Therapies Supply Chain Management Area Served and Its Competitors
Table 223. Fujifilm Cellular Dynamics Cell and Advanced Therapies Supply Chain Management Product Offered
Table 224. Fujifilm Cellular Dynamics Cell and Advanced Therapies Supply Chain Management Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 225. Fujifilm Cellular Dynamics Main Business
Table 226. Fujifilm Cellular Dynamics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Cell and Advanced Therapies Supply Chain Management Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell and Advanced Therapies Supply Chain Management Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell and Advanced Therapies Supply Chain Management Sales Market Share by Country/Region (2025)
Figure 8. Cell and Advanced Therapies Supply Chain Management Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type in 2025
Figure 10. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Supply Chain in 2025
Figure 11. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Temperature in 2025
Figure 12. Cell and Advanced Therapies Supply Chain Management in Biobank
Figure 13. Global Cell and Advanced Therapies Supply Chain Management Market: Biobank (2021-2026) & ($ millions)
Figure 14. Cell and Advanced Therapies Supply Chain Management in Cell Therapy Lab
Figure 15. Global Cell and Advanced Therapies Supply Chain Management Market: Cell Therapy Lab (2021-2026) & ($ millions)
Figure 16. Cell and Advanced Therapies Supply Chain Management in Hospital
Figure 17. Global Cell and Advanced Therapies Supply Chain Management Market: Hospital (2021-2026) & ($ millions)
Figure 18. Cell and Advanced Therapies Supply Chain Management in Research Institute
Figure 19. Global Cell and Advanced Therapies Supply Chain Management Market: Research Institute (2021-2026) & ($ millions)
Figure 20. Cell and Advanced Therapies Supply Chain Management in Commercial Organization
Figure 21. Global Cell and Advanced Therapies Supply Chain Management Market: Commercial Organization (2021-2026) & ($ millions)
Figure 22. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application in 2025
Figure 23. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Player in 2025
Figure 24. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Region (2021-2026)
Figure 25. Americas Cell and Advanced Therapies Supply Chain Management Market Size 2021-2026 ($ millions)
Figure 26. APAC Cell and Advanced Therapies Supply Chain Management Market Size 2021-2026 ($ millions)
Figure 27. Europe Cell and Advanced Therapies Supply Chain Management Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size 2021-2026 ($ millions)
Figure 29. Americas Cell and Advanced Therapies Supply Chain Management Value Market Share by Country in 2025
Figure 30. United States Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Region in 2025
Figure 35. APAC Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2021-2026)
Figure 36. APAC Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2021-2026)
Figure 37. China Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 41. India Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Country in 2025
Figure 44. Europe Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2021-2026)
Figure 45. Europe Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2021-2026)
Figure 46. Germany Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 47. France Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Cell and Advanced Therapies Supply Chain Management Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 60. APAC Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 61. Europe Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 63. United States Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 64. Canada Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 65. Mexico Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 66. Brazil Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 67. China Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 68. Japan Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 69. Korea Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 71. India Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 72. Australia Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 73. Germany Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 74. France Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 75. UK Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 76. Italy Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 77. Russia Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 78. Egypt Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 79. South Africa Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 80. Israel Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 81. Turkey Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)
Figure 82. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Cell and Advanced Therapies Supply Chain Management Market Size 2027-2032 ($ millions)